Global Dry Powder Inhaler Device Market Growth 2022-2028
As the global economy mends, the 2021 growth of Dry Powder Inhaler Device will have significant change from previous year. According to our latest study, the global Dry Powder Inhaler Device market size is USD million in 2022 from USD 769.5 million in 2021, with a change of % between 2021 and 2022. The global Dry Powder Inhaler Device market size will reach USD 1088.8 million in 2028, growing at a CAGR of 5.1% over the analysis period.
The United States Dry Powder Inhaler Device market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Dry Powder Inhaler Device market, reaching US$ million by the year 2028. As for the Europe Dry Powder Inhaler Device landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Dry Powder Inhaler Device players cover GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, and Chiesi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Dry Powder Inhaler Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Single Dose
Multi Dose
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Asthma
COPD
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Mylan
Novartis
Schering/Merck
Teva
Vectura
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dry Powder Inhaler Device Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Dry Powder Inhaler Device by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Dry Powder Inhaler Device by Country/Region, 2017, 2022 & 2028
2.2 Dry Powder Inhaler Device Segment by Type
2.2.1 Single Dose
2.2.2 Multi Dose
2.3 Dry Powder Inhaler Device Sales by Type
2.3.1 Global Dry Powder Inhaler Device Sales Market Share by Type (2017-2022)
2.3.2 Global Dry Powder Inhaler Device Revenue and Market Share by Type (2017-2022)
2.3.3 Global Dry Powder Inhaler Device Sale Price by Type (2017-2022)
2.4 Dry Powder Inhaler Device Segment by Application
2.4.1 Asthma
2.4.2 COPD
2.4.3 Others
2.5 Dry Powder Inhaler Device Sales by Application
2.5.1 Global Dry Powder Inhaler Device Sale Market Share by Application (2017-2022)
2.5.2 Global Dry Powder Inhaler Device Revenue and Market Share by Application (2017-2022)
2.5.3 Global Dry Powder Inhaler Device Sale Price by Application (2017-2022)
3 Global Dry Powder Inhaler Device by Company
3.1 Global Dry Powder Inhaler Device Breakdown Data by Company
3.1.1 Global Dry Powder Inhaler Device Annual Sales by Company (2020-2022)
3.1.2 Global Dry Powder Inhaler Device Sales Market Share by Company (2020-2022)
3.2 Global Dry Powder Inhaler Device Annual Revenue by Company (2020-2022)
3.2.1 Global Dry Powder Inhaler Device Revenue by Company (2020-2022)
3.2.2 Global Dry Powder Inhaler Device Revenue Market Share by Company (2020-2022)
3.3 Global Dry Powder Inhaler Device Sale Price by Company
3.4 Key Manufacturers Dry Powder Inhaler Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dry Powder Inhaler Device Product Location Distribution
3.4.2 Players Dry Powder Inhaler Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Dry Powder Inhaler Device by Geographic Region
4.1 World Historic Dry Powder Inhaler Device Market Size by Geographic Region (2017-2022)
4.1.1 Global Dry Powder Inhaler Device Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Dry Powder Inhaler Device Annual Revenue by Geographic Region
4.2 World Historic Dry Powder Inhaler Device Market Size by Country/Region (2017-2022)
4.2.1 Global Dry Powder Inhaler Device Annual Sales by Country/Region (2017-2022)
4.2.2 Global Dry Powder Inhaler Device Annual Revenue by Country/Region
4.3 Americas Dry Powder Inhaler Device Sales Growth
4.4 APAC Dry Powder Inhaler Device Sales Growth
4.5 Europe Dry Powder Inhaler Device Sales Growth
4.6 Middle East & Africa Dry Powder Inhaler Device Sales Growth
5 Americas
5.1 Americas Dry Powder Inhaler Device Sales by Country
5.1.1 Americas Dry Powder Inhaler Device Sales by Country (2017-2022)
5.1.2 Americas Dry Powder Inhaler Device Revenue by Country (2017-2022)
5.2 Americas Dry Powder Inhaler Device Sales by Type
5.3 Americas Dry Powder Inhaler Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dry Powder Inhaler Device Sales by Region
6.1.1 APAC Dry Powder Inhaler Device Sales by Region (2017-2022)
6.1.2 APAC Dry Powder Inhaler Device Revenue by Region (2017-2022)
6.2 APAC Dry Powder Inhaler Device Sales by Type
6.3 APAC Dry Powder Inhaler Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Dry Powder Inhaler Device by Country
7.1.1 Europe Dry Powder Inhaler Device Sales by Country (2017-2022)
7.1.2 Europe Dry Powder Inhaler Device Revenue by Country (2017-2022)
7.2 Europe Dry Powder Inhaler Device Sales by Type
7.3 Europe Dry Powder Inhaler Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dry Powder Inhaler Device by Country
8.1.1 Middle East & Africa Dry Powder Inhaler Device Sales by Country (2017-2022)
8.1.2 Middle East & Africa Dry Powder Inhaler Device Revenue by Country (2017-2022)
8.2 Middle East & Africa Dry Powder Inhaler Device Sales by Type
8.3 Middle East & Africa Dry Powder Inhaler Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dry Powder Inhaler Device
10.3 Manufacturing Process Analysis of Dry Powder Inhaler Device
10.4 Industry Chain Structure of Dry Powder Inhaler Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dry Powder Inhaler Device Distributors
11.3 Dry Powder Inhaler Device Customer
12 World Forecast Review for Dry Powder Inhaler Device by Geographic Region
12.1 Global Dry Powder Inhaler Device Market Size Forecast by Region
12.1.1 Global Dry Powder Inhaler Device Forecast by Region (2023-2028)
12.1.2 Global Dry Powder Inhaler Device Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Dry Powder Inhaler Device Forecast by Type
12.7 Global Dry Powder Inhaler Device Forecast by Application
13 Key Players Analysis
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Dry Powder Inhaler Device Product Offered
13.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Dry Powder Inhaler Device Product Offered
13.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Dry Powder Inhaler Device Product Offered
13.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Chiesi
13.4.1 Chiesi Company Information
13.4.2 Chiesi Dry Powder Inhaler Device Product Offered
13.4.3 Chiesi Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Chiesi Main Business Overview
13.4.5 Chiesi Latest Developments
13.5 Cipla
13.5.1 Cipla Company Information
13.5.2 Cipla Dry Powder Inhaler Device Product Offered
13.5.3 Cipla Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Cipla Main Business Overview
13.5.5 Cipla Latest Developments
13.6 3M
13.6.1 3M Company Information
13.6.2 3M Dry Powder Inhaler Device Product Offered
13.6.3 3M Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 3M Main Business Overview
13.6.5 3M Latest Developments
13.7 Hovione
13.7.1 Hovione Company Information
13.7.2 Hovione Dry Powder Inhaler Device Product Offered
13.7.3 Hovione Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hovione Main Business Overview
13.7.5 Hovione Latest Developments
13.8 Mannkind
13.8.1 Mannkind Company Information
13.8.2 Mannkind Dry Powder Inhaler Device Product Offered
13.8.3 Mannkind Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Mannkind Main Business Overview
13.8.5 Mannkind Latest Developments
13.9 Mylan
13.9.1 Mylan Company Information
13.9.2 Mylan Dry Powder Inhaler Device Product Offered
13.9.3 Mylan Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Mylan Main Business Overview
13.9.5 Mylan Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis Dry Powder Inhaler Device Product Offered
13.10.3 Novartis Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 Schering/Merck
13.11.1 Schering/Merck Company Information
13.11.2 Schering/Merck Dry Powder Inhaler Device Product Offered
13.11.3 Schering/Merck Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Schering/Merck Main Business Overview
13.11.5 Schering/Merck Latest Developments
13.12 Teva
13.12.1 Teva Company Information
13.12.2 Teva Dry Powder Inhaler Device Product Offered
13.12.3 Teva Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Teva Main Business Overview
13.12.5 Teva Latest Developments
13.13 Vectura
13.13.1 Vectura Company Information
13.13.2 Vectura Dry Powder Inhaler Device Product Offered
13.13.3 Vectura Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Vectura Main Business Overview
13.13.5 Vectura Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Dry Powder Inhaler Device Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Dry Powder Inhaler Device Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Single Dose
Table 4. Major Players of Multi Dose
Table 5. Global Dry Powder Inhaler Device Sales by Type (2017-2022) & (K Units)
Table 6. Global Dry Powder Inhaler Device Sales Market Share by Type (2017-2022)
Table 7. Global Dry Powder Inhaler Device Revenue by Type (2017-2022) & ($ million)
Table 8. Global Dry Powder Inhaler Device Revenue Market Share by Type (2017-2022)
Table 9. Global Dry Powder Inhaler Device Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Dry Powder Inhaler Device Sales by Application (2017-2022) & (K Units)
Table 11. Global Dry Powder Inhaler Device Sales Market Share by Application (2017-2022)
Table 12. Global Dry Powder Inhaler Device Revenue by Application (2017-2022)
Table 13. Global Dry Powder Inhaler Device Revenue Market Share by Application (2017-2022)
Table 14. Global Dry Powder Inhaler Device Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Dry Powder Inhaler Device Sales by Company (2020-2022) & (K Units)
Table 16. Global Dry Powder Inhaler Device Sales Market Share by Company (2020-2022)
Table 17. Global Dry Powder Inhaler Device Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Dry Powder Inhaler Device Revenue Market Share by Company (2020-2022)
Table 19. Global Dry Powder Inhaler Device Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Dry Powder Inhaler Device Producing Area Distribution and Sales Area
Table 21. Players Dry Powder Inhaler Device Products Offered
Table 22. Dry Powder Inhaler Device Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Dry Powder Inhaler Device Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Dry Powder Inhaler Device Sales Market Share Geographic Region (2017-2022)
Table 27. Global Dry Powder Inhaler Device Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Dry Powder Inhaler Device Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Dry Powder Inhaler Device Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Dry Powder Inhaler Device Sales Market Share by Country/Region (2017-2022)
Table 31. Global Dry Powder Inhaler Device Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Dry Powder Inhaler Device Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Dry Powder Inhaler Device Sales by Country (2017-2022) & (K Units)
Table 34. Americas Dry Powder Inhaler Device Sales Market Share by Country (2017-2022)
Table 35. Americas Dry Powder Inhaler Device Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Dry Powder Inhaler Device Revenue Market Share by Country (2017-2022)
Table 37. Americas Dry Powder Inhaler Device Sales by Type (2017-2022) & (K Units)
Table 38. Americas Dry Powder Inhaler Device Sales Market Share by Type (2017-2022)
Table 39. Americas Dry Powder Inhaler Device Sales by Application (2017-2022) & (K Units)
Table 40. Americas Dry Powder Inhaler Device Sales Market Share by Application (2017-2022)
Table 41. APAC Dry Powder Inhaler Device Sales by Region (2017-2022) & (K Units)
Table 42. APAC Dry Powder Inhaler Device Sales Market Share by Region (2017-2022)
Table 43. APAC Dry Powder Inhaler Device Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Dry Powder Inhaler Device Revenue Market Share by Region (2017-2022)
Table 45. APAC Dry Powder Inhaler Device Sales by Type (2017-2022) & (K Units)
Table 46. APAC Dry Powder Inhaler Device Sales Market Share by Type (2017-2022)
Table 47. APAC Dry Powder Inhaler Device Sales by Application (2017-2022) & (K Units)
Table 48. APAC Dry Powder Inhaler Device Sales Market Share by Application (2017-2022)
Table 49. Europe Dry Powder Inhaler Device Sales by Country (2017-2022) & (K Units)
Table 50. Europe Dry Powder Inhaler Device Sales Market Share by Country (2017-2022)
Table 51. Europe Dry Powder Inhaler Device Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Dry Powder Inhaler Device Revenue Market Share by Country (2017-2022)
Table 53. Europe Dry Powder Inhaler Device Sales by Type (2017-2022) & (K Units)
Table 54. Europe Dry Powder Inhaler Device Sales Market Share by Type (2017-2022)
Table 55. Europe Dry Powder Inhaler Device Sales by Application (2017-2022) & (K Units)
Table 56. Europe Dry Powder Inhaler Device Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Dry Powder Inhaler Device Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Dry Powder Inhaler Device Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Dry Powder Inhaler Device Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Dry Powder Inhaler Device Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Dry Powder Inhaler Device Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Dry Powder Inhaler Device Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Dry Powder Inhaler Device Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Dry Powder Inhaler Device Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Dry Powder Inhaler Device
Table 66. Key Market Challenges & Risks of Dry Powder Inhaler Device
Table 67. Key Industry Trends of Dry Powder Inhaler Device
Table 68. Dry Powder Inhaler Device Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Dry Powder Inhaler Device Distributors List
Table 71. Dry Powder Inhaler Device Customer List
Table 72. Global Dry Powder Inhaler Device Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Dry Powder Inhaler Device Sales Market Forecast by Region
Table 74. Global Dry Powder Inhaler Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Dry Powder Inhaler Device Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Dry Powder Inhaler Device Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Dry Powder Inhaler Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Dry Powder Inhaler Device Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Dry Powder Inhaler Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Dry Powder Inhaler Device Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Dry Powder Inhaler Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Dry Powder Inhaler Device Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Dry Powder Inhaler Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Dry Powder Inhaler Device Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Dry Powder Inhaler Device Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Dry Powder Inhaler Device Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Dry Powder Inhaler Device Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Dry Powder Inhaler Device Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Dry Powder Inhaler Device Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Dry Powder Inhaler Device Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Dry Powder Inhaler Device Revenue Market Share Forecast by Application (2023-2028)
Table 92. GlaxoSmithKline Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 93. GlaxoSmithKline Dry Powder Inhaler Device Product Offered
Table 94. GlaxoSmithKline Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. GlaxoSmithKline Main Business
Table 96. GlaxoSmithKline Latest Developments
Table 97. AstraZeneca Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 98. AstraZeneca Dry Powder Inhaler Device Product Offered
Table 99. AstraZeneca Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. AstraZeneca Main Business
Table 101. AstraZeneca Latest Developments
Table 102. Boehringer Ingelheim Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 103. Boehringer Ingelheim Dry Powder Inhaler Device Product Offered
Table 104. Boehringer Ingelheim Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Boehringer Ingelheim Main Business
Table 106. Boehringer Ingelheim Latest Developments
Table 107. Chiesi Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 108. Chiesi Dry Powder Inhaler Device Product Offered
Table 109. Chiesi Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Chiesi Main Business
Table 111. Chiesi Latest Developments
Table 112. Cipla Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 113. Cipla Dry Powder Inhaler Device Product Offered
Table 114. Cipla Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Cipla Main Business
Table 116. Cipla Latest Developments
Table 117. 3M Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 118. 3M Dry Powder Inhaler Device Product Offered
Table 119. 3M Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. 3M Main Business
Table 121. 3M Latest Developments
Table 122. Hovione Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 123. Hovione Dry Powder Inhaler Device Product Offered
Table 124. Hovione Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Hovione Main Business
Table 126. Hovione Latest Developments
Table 127. Mannkind Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 128. Mannkind Dry Powder Inhaler Device Product Offered
Table 129. Mannkind Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Mannkind Main Business
Table 131. Mannkind Latest Developments
Table 132. Mylan Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 133. Mylan Dry Powder Inhaler Device Product Offered
Table 134. Mylan Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Mylan Main Business
Table 136. Mylan Latest Developments
Table 137. Novartis Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 138. Novartis Dry Powder Inhaler Device Product Offered
Table 139. Novartis Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Novartis Main Business
Table 141. Novartis Latest Developments
Table 142. Schering/Merck Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 143. Schering/Merck Dry Powder Inhaler Device Product Offered
Table 144. Schering/Merck Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 145. Schering/Merck Main Business
Table 146. Schering/Merck Latest Developments
Table 147. Teva Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 148. Teva Dry Powder Inhaler Device Product Offered
Table 149. Teva Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 150. Teva Main Business
Table 151. Teva Latest Developments
Table 152. Vectura Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 153. Vectura Dry Powder Inhaler Device Product Offered
Table 154. Vectura Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 155. Vectura Main Business
Table 156. Vectura Latest Developments
List of Figures
Figure 1. Picture of Dry Powder Inhaler Device
Figure 2. Dry Powder Inhaler Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dry Powder Inhaler Device Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Dry Powder Inhaler Device Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Dry Powder Inhaler Device Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Single Dose
Figure 10. Product Picture of Multi Dose
Figure 11. Global Dry Powder Inhaler Device Sales Market Share by Type in 2021
Figure 12. Global Dry Powder Inhaler Device Revenue Market Share by Type (2017-2022)
Figure 13. Dry Powder Inhaler Device Consumed in Asthma
Figure 14. Global Dry Powder Inhaler Device Market: Asthma (2017-2022) & (K Units)
Figure 15. Dry Powder Inhaler Device Consumed in COPD
Figure 16. Global Dry Powder Inhaler Device Market: COPD (2017-2022) & (K Units)
Figure 17. Dry Powder Inhaler Device Consumed in Others
Figure 18. Global Dry Powder Inhaler Device Market: Others (2017-2022) & (K Units)
Figure 19. Global Dry Powder Inhaler Device Sales Market Share by Application (2017-2022)
Figure 20. Global Dry Powder Inhaler Device Revenue Market Share by Application in 2021
Figure 21. Dry Powder Inhaler Device Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Dry Powder Inhaler Device Revenue Market Share by Company in 2021
Figure 23. Global Dry Powder Inhaler Device Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Dry Powder Inhaler Device Revenue Market Share by Geographic Region in 2021
Figure 25. Global Dry Powder Inhaler Device Sales Market Share by Region (2017-2022)
Figure 26. Global Dry Powder Inhaler Device Revenue Market Share by Country/Region in 2021
Figure 27. Americas Dry Powder Inhaler Device Sales 2017-2022 (K Units)
Figure 28. Americas Dry Powder Inhaler Device Revenue 2017-2022 ($ Millions)
Figure 29. APAC Dry Powder Inhaler Device Sales 2017-2022 (K Units)
Figure 30. APAC Dry Powder Inhaler Device Revenue 2017-2022 ($ Millions)
Figure 31. Europe Dry Powder Inhaler Device Sales 2017-2022 (K Units)
Figure 32. Europe Dry Powder Inhaler Device Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Dry Powder Inhaler Device Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Dry Powder Inhaler Device Revenue 2017-2022 ($ Millions)
Figure 35. Americas Dry Powder Inhaler Device Sales Market Share by Country in 2021
Figure 36. Americas Dry Powder Inhaler Device Revenue Market Share by Country in 2021
Figure 37. United States Dry Powder Inhaler Device Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Dry Powder Inhaler Device Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Dry Powder Inhaler Device Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Dry Powder Inhaler Device Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Dry Powder Inhaler Device Sales Market Share by Region in 2021
Figure 42. APAC Dry Powder Inhaler Device Revenue Market Share by Regions in 2021
Figure 43. China Dry Powder Inhaler Device Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Dry Powder Inhaler Device Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Dry Powder Inhaler Device Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Dry Powder Inhaler Device Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Dry Powder Inhaler Device Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Dry Powder Inhaler Device Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Dry Powder Inhaler Device Sales Market Share by Country in 2021
Figure 50. Europe Dry Powder Inhaler Device Revenue Market Share by Country in 2021
Figure 51. Germany Dry Powder Inhaler Device Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Dry Powder Inhaler Device Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Dry Powder Inhaler Device Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Dry Powder Inhaler Device Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Dry Powder Inhaler Device Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Dry Powder Inhaler Device Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Dry Powder Inhaler Device Revenue Market Share by Country in 2021
Figure 58. Egypt Dry Powder Inhaler Device Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Dry Powder Inhaler Device Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Dry Powder Inhaler Device Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Dry Powder Inhaler Device Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Dry Powder Inhaler Device Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Dry Powder Inhaler Device in 2021
Figure 64. Manufacturing Process Analysis of Dry Powder Inhaler Device
Figure 65. Industry Chain Structure of Dry Powder Inhaler Device
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
